Companies: 10,795·Total market cap: $144.5T
Mustang Bio, Inc.

Mustang Bio, Inc.

MBIONASDAQHealthcare● Active
$0.70
+$0.03(+4.49%)
Market Cap$5305011
P/E Ratio
52W High$7
52W Low$0.531
Overview

Mustang Bio, Inc.(MBIO)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MBIO · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.42mbio eps ttm · mbio earnings per shareEarnings history
PE Ratio (TTM)mbio pe ratio ttm · mbio price to earningsPE Ratio deep dive
Revenue (TTM)0.00mbio revenue ttm · mbio annual revenueFull revenue history
Dividend Yield不分红does mbio pay dividends · mbio dividend yieldDividend history
Shares Outstanding4.9Mmbio shares outstanding · mbio floatShares outstanding history
Next EarningsAug 18, 2026Est.mbio earnings date · mbio next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
mustang bio, inc. revenue · mbio revenue 2025
FY 2025Net Income-$1.9M▲ +87.80% YoY
202320242025
mustang bio, inc. net income · mbio profit 2025
FY 2025EPS$-0.39▲ +84.82% YoY
202320242025
mbio eps · mustang bio, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$2.7MEPS: $-0.42View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy7 位分析师is mbio a buy · mbio analyst rating
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.70Current
$Avg Target
$High
mbio price target · mbio 12 month forecast

合计: 7 · 买入占比: 100.0%

股票表现

完整历史
1D+4.49%
1W-7.42%
1M+0.59%
3M-21.89%
YTD-28.63%
1Y-45.73%
5Y-99.98%

关于 Mustang Bio, Inc.

CEOManuel Litchman
IPO DateAug 22, 2017
Employees6
CountryUS

Mustang Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to transforming groundbreaking advancements in cell and gene therapies into potential therapeutic options for hematological malig…

what is mustang bio, inc. · mbio stock overview · mustang bio, inc. company profile · who is mustang bio, inc. ceo · mbio NASDAQ · mustang bio, inc. headquarters · mustang bio, inc. business segments

关于股票概览与关键数据

Mustang Bio, Inc.(MBIO)是 Biotechnology 行业的 Healthcare 类公司,于 Aug 22, 2017 在 NASDAQ 上市。截至最近交易日,MBIO 股价为 $0.70,市值约为 $5.3M。过去12个月累计回报 -45.73%,年初至今回报 -28.63%。

根据 7 位华尔街分析师,Mustang Bio, Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Mustang Bio, Inc. 营收 —,净利润 -$1.9M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Mustang Bio, Inc.(MBIO)股价为 $0.70,在 NASDAQ 上市,52周区间为 $0.53 – $7.00。

MBIO 最新股价MBIO quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议